Home ETF List About

Portfolio Holdings Detail for ISIN IE000D8XC064
Stock Name / FundiShares World Equity Enhanced Active UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares III Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300PZLRJB7M8H1057
ETF TickerWOEE(GBP) LSE
ETF TickerWOEE.AS(USD) AS
ETF TickerWOEE.AS(USD) Euronext Amsterdam

Holdings detail for LLY

Stock NameEli Lilly and Company
TickerLLY(EUR) F
TYPECommon Stock
CountryGermany
ISINUS5324571083
LEIFRDRIPF3EKNDJ2CQJL29

Show aggregate LLY holdings

News associated with LLY

Notable Friday Option Activity: AMD, LLY, BKNG
Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Advanced Micro Devices Inc (Symbol: AMD), where a total volume of 570,924 contracts has been traded thus far today, a contract volume which is representative of a - 2025-09-19 14:45:00
Boost Your Portfolio With These Top-Ranked ETFs
With the Fed's first 2025 rate cut and upgraded growth outlook, ETFs in tech, financials, industrials and health care could benefit from momentum. - 2025-09-19 13:03:00
3 Dividend Growth Stocks You Can Buy and Forget About
Key PointsThese stocks offer seemingly low yields of less than 1%. - 2025-09-18 05:50:00
JPMorgan Chase & Co. Has Lowered Expectations for Eli Lilly and Company (NYSE:LLY) Stock Price
Eli Lilly and Company (NYSE:LLY – Get Free Report) had its price objective decreased by JPMorgan Chase & Co. from $1,100.00 to $1,050.00 in a research report issued on Tuesday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price target indicates a potential upside of 38.09% from the […] - 2025-09-18 02:56:56
Lilly's Orforglipron Achieves Significant Weight Loss In Phase 3 Trial
(RTTNews) - Eli Lilly and Co. (LLY) announced detailed results from its Phase 3 ATTAIN-1 trial, evaluating the safety and efficacy of orforglipron—an investigational oral glucagon-like peptide-1 (GLP-1) receptor agonist—in adults with obesity, or those overweight with a weight-re - 2025-09-17 00:35:16
XLV, LLY, TMO, PFE: Large Inflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the The Health Care Select Sector SPDR Fund (Symbol: XLV) where we have detected an approximate $308.0 million dollar inflow -- that's a 0.9% increase we - 2025-09-16 11:47:58
S&P 500 Analyst Moves: LLY
The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, Eli Lilly is now the #61 analyst pick, moving up by 1 spot. This rank is formed by averaging the analyst opinions for each component from each - 2025-09-15 14:35:56
Why Novo Nordisk Stock Popped Today
Key PointsLondon's Financial Times highlights improved weight loss from taking more Ozempic. - 2025-09-15 12:34:46
Sen. John Boozman Buys Eli Lilly and Company (NYSE:LLY) Stock
Senator John Boozman (R-Arkansas) recently bought shares of Eli Lilly and Company (NYSE:LLY). In a filing disclosed on September 12th, the Senator disclosed that they had bought between $1,001 and $15,000 in Eli Lilly and Company stock on August 11th. Senator John Boozman also recently made the following trade(s): Purchased $1,001 – $15,000 in shares […] - 2025-09-15 03:12:42
3 Monster Stocks to Hold for the Next 5 Years
Key PointsAmazon should improve its profits and margins, based on its cloud computing and AI initiatives. - 2025-09-14 08:45:00
2 Beaten-Down Stocks to Buy and Hold Forever
Key PointsApple and Eli Lilly have impressive long-term track records of returns. - 2025-09-13 08:45:00
2 Monster Stocks to Hold for the Next 5 Years
Key PointsThese stocks have climbed in the triple digits over the past three years. - 2025-09-11 05:20:00
IWB, LLY, ORCL, CVX: Large Inflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 1000 ETF (Symbol: IWB) where we have detected an approximate $462.9 million dollar inflow -- that's a 1.1% increase week over week in - 2025-09-08 12:03:03
Down 34%, Should You Buy the Dip on Viking Therapeutics?
Key PointsViking Therapeutics is working on an injectable weight loss drug candidate and one in pill format. - 2025-09-05 05:10:00
The 6 Best Stocks to Buy Right Now in September (2025)!
My list of best stocks to buy has outperformed the broader market indexes by a significant margin. - 2025-09-04 06:00:00
The Problem With Weight Loss Stocks
In this Motley Fool Money episode, Motley Fool analysts Rick Munarriz and Karl Thiel and contributor Jason Hall dig into the problems with weight loss stocks. They also look at some investments that can survive near-term potential volatility as well as give a long-term view of di - 2025-09-03 14:48:00
NVO's Wegovy vs. LLY's Tirzepatide: Who Leads in Heart Risk Reduction?
Novo Nordisk's Wegovy shows a stronger reduction in heart risks compared to Eli Lilly's tirzepatide in real-world data from the STEER study. - 2025-09-01 11:54:00
The Zacks Analyst Blog Highlights Lilly, Oracle, Procter & Gamble and Comstock Holding Companies
Zacks spotlights Eli Lilly, Oracle, Procter & Gamble, and microcap Comstock Holding, with pharma and staples facing pressure while Oracle and Comstock show momentum. - 2025-08-29 13:58:00
Nvidia's $46.7 Billion Quarter Shows the AI Trade Is Alive and Well -- With Caveats
Key PointsWhile earnings were up 56%, the company's data center revenue dropped 1% sequentially. - 2025-08-29 05:45:00
Top Stock Reports for Eli Lilly, Oracle & Procter & Gamble
Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly, Oracle, and Procter & Gamble, as well as a micro-cap stock, Comstock. - 2025-08-28 18:59:00
2 Growth Stocks That Could Be Worth $1 Trillion in 5 Years
Key PointsEli Lilly's work in weight management should help it surpass some industry sales records. - 2025-08-28 10:45:00
2 High-Yield Dividend Stocks You Can Buy With $200 Now and Hold at Least a Decade
Key PointsDividend-paying stocks tend to outperform non-dividend-paying stocks by a mile. - 2025-08-28 04:26:00
As the Market Rotates, This Healthcare ETF Is Leading the Way
Over the past month, the market has undergone a rotation that’s seen tech sell-off and defensive sectors like healthcare reap the rewards. The jury remains out on whether this shift indicates a more inclusive rally or if it should raise questions about the bull market’s footing. - 2025-08-26 10:35:00
When AI Execs Say the Market Looks Bubbly
In this podcast, Motley Fool contributors Tyler Crowe, Lou Whiteman, and Rachel Warren discuss: - 2025-08-25 14:47:00
Eli Lilly and Company (NYSE:LLY) and Innoviva (NASDAQ:INVA) Financial Analysis
Eli Lilly and Company (NYSE:LLY – Get Free Report) and Innoviva (NASDAQ:INVA – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings. Institutional & Insider Ownership 82.5% of Eli […] - 2025-08-25 04:38:49
The S&P 500 Hasn't Yielded This Little Since the Dot-Com Bubble. Here's What Investors Can Do.
Key PointsThe S&P 500's rising yield is similar to what happened before the dot-com bubble burst. - 2025-08-24 15:23:00
The Best Stocks to Invest $50,000 in Right Now
Key PointsIf you have a lump sum of money, look for long-term performance and stability. - 2025-08-24 05:32:00
If I Could Only Buy 1 S&P 500 Stock From Each Sector for the Rest of 2025, I'd Go With These 11 Dividend Stocks
Key PointsSome stock market sectors significantly impact the S&P 500, whereas others barely make a dent. - 2025-08-23 19:05:00
Is the Vanguard Mega Cap ETF the Simplest Way to Invest in the Top S&P 500 Stocks?
Key PointsThe fund targets the 37% largest S&P 500 components by market cap. - 2025-08-23 17:05:00
Warren Buffett Makes a Big Buy
In this podcast, Motley Fool contributors Travis Hoium, Lou Whiteman, and Rick Munarriz discuss: - 2025-08-22 17:55:00

iShares World Equity Enhanced Active UCITS ETF USD (Acc) LLY holdings

DateNumber of LLY Shares HeldBase Market Value of LLY SharesLocal Market Value of LLY SharesChange in LLY Shares HeldChange in LLY Base ValueCurrent Price per LLY Share HeldPrevious Price per LLY Share Held
2025-11-13 (Thursday)10,558USD 10,799,461USD 10,799,461
2025-11-12 (Wednesday)10,417USD 10,602,214LLY holding increased by 303759USD 10,602,2140USD 303,759 USD 1017.78 USD 988.62
2025-11-11 (Tuesday)10,417USD 10,298,455LLY holding increased by 228966USD 10,298,4550USD 228,966 USD 988.62 USD 966.64
2025-11-10 (Monday)10,417LLY holding decreased by -72USD 10,069,489LLY holding increased by 373772USD 10,069,489-72USD 373,772 USD 966.64 USD 924.37
2025-11-07 (Friday)10,489LLY holding increased by 168USD 9,695,717LLY holding increased by 20399USD 9,695,717168USD 20,399 USD 924.37 USD 937.44
2025-11-06 (Thursday)10,321LLY holding increased by 148USD 9,675,318LLY holding increased by 257053USD 9,675,318148USD 257,053 USD 937.44 USD 925.81
2025-11-05 (Wednesday)10,173LLY holding increased by 24USD 9,418,265LLY holding increased by 214543USD 9,418,26524USD 214,543 USD 925.81 USD 906.86
2025-11-04 (Tuesday)10,149LLY holding increased by 472USD 9,203,722LLY holding increased by 528001USD 9,203,722472USD 528,001 USD 906.86 USD 896.53
2025-11-03 (Monday)9,677USD 8,675,721LLY holding increased by 325825USD 8,675,7210USD 325,825 USD 896.53 USD 862.86
2025-10-31 (Friday)9,677USD 8,349,896LLY holding increased by 177669USD 8,349,8960USD 177,669 USD 862.86 USD 844.5
2025-10-30 (Thursday)9,677LLY holding increased by 170USD 8,172,227LLY holding increased by 437997USD 8,172,227170USD 437,997 USD 844.5 USD 813.53
2025-10-29 (Wednesday)9,507LLY holding increased by 360USD 7,734,230LLY holding increased by 232775USD 7,734,230360USD 232,775 USD 813.53 USD 820.1
2025-10-28 (Tuesday)9,147LLY holding increased by 251USD 7,501,455LLY holding increased by 149712USD 7,501,455251USD 149,712 USD 820.1 USD 826.41
2025-10-27 (Monday)8,896LLY holding increased by 112USD 7,351,743LLY holding increased by 100990USD 7,351,743112USD 100,990 USD 826.41 USD 825.45
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of LLY by Blackrock for IE000D8XC064

Show aggregate share trades of LLY

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-10SELL-72981.990938.830 943.146EUR -67,907 805.61 Loss of -9,902 on sale
2025-11-07BUY168 924.370* 804.86
2025-11-06BUY148949.890916.263 919.626EUR 136,105 804.03
2025-11-05BUY24955.410908.230 912.948EUR 21,911 803.25
2025-11-04BUY472915.220883.640 886.798EUR 418,569 802.59
2025-10-30BUY170853.000812.250 816.325EUR 138,775 801.30
2025-10-29BUY360813.530830.290 828.614EUR 298,301 801.22
2025-10-28BUY251820.100829.460 828.524EUR 207,960 801.10
2025-10-27BUY112826.410826.420 826.419EUR 92,559 800.93
2025-10-24BUY24825.450834.150 833.280EUR 19,999 800.77
2025-10-20BUY693808.960809.410 809.365EUR 560,890 800.50
2025-10-16BUY283819.380834.700 833.168EUR 235,787 800.35
2025-10-15BUY344826.570830.190 829.828EUR 285,461 800.16
2025-10-06BUY16845.050856.570 855.418EUR 13,687 799.53
2025-10-03BUY136839.870848.130 847.304EUR 115,233 799.24
2025-10-02BUY147819.850834.460 832.999EUR 122,451 799.09
2025-08-12BUY252639.430646.180 645.505EUR 162,667 800.90
2025-08-11BUY45635.220654.440 652.518EUR 29,363 802.14
2025-08-07BUY18640.860678.290 674.547EUR 12,142 803.37
2025-08-04BUY27769.000774.480 773.932EUR 20,896 804.37
2025-07-31BUY22740.070766.450 763.812EUR 16,804 805.20
2025-07-22BUY36776.440778.290 778.105EUR 28,012 806.20
2025-07-21BUY243762.180772.000 771.018EUR 187,357 806.56
2025-07-17SELL-12761.500790.000 787.150EUR -9,446 807.22 Profit of 241 on sale
2025-07-11BUY135793.010795.730 795.458EUR 107,387 807.87
2025-07-10BUY80790.650799.490 798.606EUR 63,888 808.02
2025-07-09BUY110786.920794.000 793.292EUR 87,262 808.21
2025-07-02BUY22779.280779.840 779.784EUR 17,155 808.96
2025-06-30BUY99779.530785.000 784.453EUR 77,661 809.23
2025-06-26BUY45795.120798.800 798.432EUR 35,929 809.67
2025-06-25BUY198792.300798.950 798.285EUR 158,060 809.84
2025-06-16BUY45807.580825.000 823.258EUR 37,047 810.84
2025-06-13BUY54819.360825.000 824.436EUR 44,520 810.75
2025-06-12BUY103812.030818.560 817.907EUR 84,244 810.74
2025-06-11BUY494808.610820.720 819.509EUR 404,837 810.76
2025-06-10BUY22807.190808.630 808.486EUR 17,787 810.80
2025-06-06BUY44769.880772.600 772.328EUR 33,982 811.61
2025-06-02BUY22747.120747.370 747.345EUR 16,442 813.97
2025-05-30BUY14737.670745.900 745.077EUR 10,431 814.81
2025-05-28BUY45719.390729.990 728.930EUR 32,802 816.92
2025-05-22BUY9715.200722.190 721.491EUR 6,493 820.37
2025-05-14BUY36715.560759.500 755.106EUR 27,184 826.48
2025-05-13BUY18746.060759.500 758.156EUR 13,647 827.50
2025-05-12BUY171755.570765.330 764.354EUR 130,705 828.42
2025-05-01BUY21794.100850.930 845.247EUR 17,750 832.95
2025-04-30BUY216898.950902.500 902.145EUR 194,863 832.01
2025-04-29BUY531885.200892.470 891.743EUR 473,516 831.24
2025-04-28BUY9877.290882.250 881.754EUR 7,936 830.56
2025-04-24SELL-27859.730862.250 861.998EUR -23,274 829.30 Loss of -883 on sale
2025-04-23BUY36829.420846.010 844.351EUR 30,397 829.30
2025-04-17SELL-18839.960858.000 856.196EUR -15,412 829.16 Loss of -487 on sale
2025-04-16BUY135734.900756.300 754.160EUR 101,812 830.73
2025-04-15BUY63757.180765.310 764.497EUR 48,163 831.98
2025-04-09BUY7753.710754.830 754.718EUR 5,283 838.65
2025-04-08BUY63726.240763.500 759.774EUR 47,866 840.73
2025-04-07BUY432723.730748.000 745.573EUR 322,088 842.93
2025-04-04BUY464738.210768.270 765.264EUR 355,083 844.95
2025-04-01BUY81805.230820.660 819.117EUR 66,348 846.28
2025-03-31BUY54825.910828.010 827.800EUR 44,701 846.69
2025-03-28BUY79822.510829.780 829.053EUR 65,495 847.20
2025-03-27BUY18821.670826.770 826.260EUR 14,873 847.74
2025-03-26BUY117826.760851.410 848.945EUR 99,327 848.20
2025-03-24BUY81864.900866.870 866.673EUR 70,201 847.72
2025-03-19SELL-36837.010842.130 841.618EUR -30,298 848.36 Profit of 243 on sale
2025-03-13BUY4801.650821.110 819.164EUR 3,277 851.90
2025-03-12BUY27821.860834.650 833.371EUR 22,501 852.73
2025-03-07BUY45869.580908.000 904.158EUR 40,687 853.79
2025-02-04BUY9826.070829.040 828.743EUR 7,459 805.79
2025-01-30BUY7823.230824.620 824.481EUR 5,771 802.75
2025-01-29BUY27804.080809.120 808.616EUR 21,833 802.58
2025-01-28BUY27804.990816.150 815.034EUR 22,006 802.24
2025-01-27BUY234808.170809.250 809.142EUR 189,339 801.25
2025-01-24BUY117785.410789.290 788.902EUR 92,302 804.42
2024-12-05BUY22825.620831.130 830.579EUR 18,273 0.00
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of LLY

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19432,0389351,319,85332.7%
2025-09-18547,8181261,290,14742.5%
2025-09-17437,3374271,166,20437.5%
2025-09-16532,6981,8291,463,37436.4%
2025-09-15424,9797011,071,48739.7%
2025-09-12267,121172826,80232.3%
2025-09-11249,8031,484850,46129.4%
2025-09-10415,4421,025989,00842.0%
2025-09-09559,8056671,270,80044.1%
2025-09-08856,0184,6821,937,44744.2%
2025-09-05679,2761,0501,405,23948.3%
2025-09-04337,49153982,75134.3%
2025-09-03214,691496766,15728.0%
2025-09-02430,4772,9771,131,90838.0%
2025-08-29357,538602889,50940.2%
2025-08-28433,6871,0991,113,56838.9%
2025-08-27860,7156,0091,681,35351.2%
2025-08-261,548,46012,1052,955,34852.4%
2025-08-25566,4543,5861,323,24942.8%
2025-08-22749,6151,9571,460,71351.3%
2025-08-21651,6392231,570,06741.5%
2025-08-20679,5542,6981,870,24136.3%
2025-08-19787,9099352,788,74028.3%
2025-08-18756,1431,0951,727,60343.8%
2025-08-151,814,7218363,422,26053.0%
2025-08-141,852,9405,3823,602,82951.4%
2025-08-131,254,2253,4732,774,10045.2%
2025-08-12990,1103,1902,845,89634.8%
2025-08-111,290,0631,6155,196,30224.8%
2025-08-082,448,706300,8706,239,83039.2%
2025-08-074,197,951489,61810,364,29440.5%
2025-08-06440,1441,1201,811,26224.3%
2025-08-05331,460921993,17833.4%
2025-08-04474,9051,4081,273,99537.3%
2025-08-01530,5697,1391,882,09828.2%
2025-07-31882,5063,6702,110,03041.8%
2025-07-30745,6143921,827,43540.8%
2025-07-291,081,8495712,607,24541.5%
2025-07-28304,8417,4601,004,03230.4%
2025-07-25365,4172651,055,27334.6%
2025-07-24321,7997621,167,14727.6%
2025-07-23485,7193,4711,044,91946.5%
2025-07-22241,0983,036874,71727.6%
2025-07-21418,0148541,180,44535.4%
2025-07-18623,4986511,225,33350.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.